Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance

Authors:

Abstract
In the US, most moderate-risk medical devices enter the market through the US Food and Drug Administration (FDA) 510(k) clearance pathway because they are “substantially equivalent” to 1 or more “predicate” devices (legally marketed devices with similar intended use).1,2 The FDA often evaluates substantial equivalence via similarities in the composition and design between applicant medical devices and predicate medical devices, and human clinical data for the applicant device or the predicate device are not typically required.3 Manufacturers may cite competitors’ devices or recalled devices as predicate medical devices as long as the recalled devices were voluntarily recalled by their manufacturers.4,5